Skip to content

Breathing-Induced Myocardial Oxygenation Reserve

Breathing-Induced Myocardial Oxygenation Reserve - Pilot Study (B-MORE-Pilot)

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03050346
Acronym
B-MORE-Pilot
Enrollment
113
Registered
2017-02-10
Start date
2016-01-31
Completion date
2022-03-24
Last updated
2022-10-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coronary Artery Disease

Keywords

Magnetic Resonance Imaging, Coronary Artery Disease, Apnea, Hyperventilation, BOLD, Breathing Maneuvers, Myocardial Oxygenation

Brief summary

This is a clinical trial to test the clinical feasibility and safety of a novel CMR protocol, combined with a specific breathing maneuver to identify myocardial regions exposed to severe coronary artery stenosis.

Detailed description

This is a clinical trial to test the clinical feasibility and safety of a novel CMR protocol. It aims to investigate a new Cardiovascular Magnetic Resonance (CMR) technique, called oxygenation-sensitive CMR (OS-CMR). OS-CMR is a T2\*-sensitive CMR sequence based on the so-called blood-oxygen-level-dependent (BOLD) effect. Because de-oxygenated hemoglobin acts as an endogenous paramagnetic contrast agent, the signal intensity (SI) in OS-CMR images is linearly correlated with hemoglobin oxygenation in the tissue. An increase in deoxyhemoglobin results in an drop in SI in OS-CMR images, while an increase in tissue oxygenation results in an increase in SI. Therefore, OS-CMR has been found capable of assessing myocardial oxygenation and is being increasingly used to identify the vascular response of the coronary circulation to different stimuli. Very recently, OS-CMR was used to identify the coronary vascular response to specific breathing maneuvers. Specifically, a marked increase of myocardial oxygenation was observed during a long breath-hold following a 60s period of hyperventilation. The combination of these two maneuvers appear to induce consistent and detectable changes of myocardial oxygenation, based on CO2-mediated coronary vasoconstriction and vasodilation, while being well tolerated by participants. In this study, the investigators will use breathing maneuvers as coronary vasoactive stimuli to assess the myocardial oxygenation changes induced by such maneuvers with OS-CMR. The investigators aim to assess if the breathing-induced relative increase of myocardial oxygenation (Breathing-induced Myocardial Oxygenation REserve, B-MORE) in a coronary territory is clinically feasible to serve as a marker for the severity of coronary artery stenosis. Moreover, the investigators will assess the feasibility and safety of OS-CMR with breathing maneuvers in patients with suspected coronary artery disease in a multi-center setting.

Interventions

None listed

Sponsors

University Hospital Heidelberg
CollaboratorOTHER
Groote Schuur Hospital
CollaboratorUNKNOWN
King's College London
CollaboratorOTHER
University of Wisconsin, Madison
CollaboratorOTHER
Jewish General Hospital
CollaboratorOTHER
McGill University Health Centre/Research Institute of the McGill University Health Centre
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Age \> 18 y * Informed consent as documented by signature (Appendix Informed Consent Form) * Indication for invasive coronary angiography based on symptoms and a test positive for inducible coronary ischemia * One-vessel or two-vessel CAD at coronary angiography (For healthy volunteers: absence of current or pre-existing cardiovascular and lung disease and absence of medication with cardiovascular effects)

Exclusion criteria

* General MRI contraindications (i.e pacemakers, defibrillating wires, implanted defibrillators, intracranial aneurysm clips, metallic foreign bodies in the eyes, knowledge or suspicion of pregnancy) * Acute Coronary Syndrome (ACS) or other acute cardiac injury within 4 weeks * Previous myocardial infarction, percutaneous coronary intervention or coronary artery bypass surgery * Hemodynamically unstable conditions * Significant or uncontrolled arrhythmias * Lack of ability to follow commands * Vasoactive medication (e.g. nitro or ß blockers) or nutrition with caffeine (coffee, tea, cocoa, chocolate, energy drink) during the 12 h before the exam * Non-ischemic cardiomyopathy * Severe Pulmonary Disease

Design outcomes

Primary

MeasureTime frameDescription
Comparison of myocardial oxygenation signal intensity changes (OS-SI) changes between healthy and post-stenotic myocardium during OS-CMR with breathing-maneuvers in CAD patients.OS-CMR with breathing maneuvers will last about 5-10 minutesMyocardial oxygenation signal intensity changes (OS-SI) changes between healthy and post-stenotic myocardium during OS-CMR with breathing-maneuvers

Secondary

MeasureTime frameDescription
Relationship between OS-SI changes during OS-CMR with breathing-maneuvers and Fractional Flow Reserve (FFR) measurements in CAD patientsOS-CMR with breathing maneuvers will last about 5-10 minutesMyocardial oxygenation signal intensity changes (OS-SI) changes during OS-CMR with breathing-maneuvers and its relation to Fractional Flow Reserve (FFR) measurements
Relationship between OS-SI changes during OS-CMR with breathing-maneuvers and Quantitative Coronary Angiography (QCA) measurements in CAD patientsOS-CMR with breathing maneuvers will last about 5-10 minutesMyocardial oxygenation signal intensity changes (OS-SI) changes during OS-CMR with breathing-maneuvers and its relation to Quantitative Coronary Angiography (QCA) measurements
Presence of side effects during OS-CMR with breathing maneuversOS-CMR with breathing maneuvers will last about 5-10 minutesside effects experienced by the participants during breathing maneuvers
Clinical feasibility of OS-CMR with breathing maneuversOS-CMR with breathing maneuvers will last about 5-10 minutesNumber of participants who voluntarily stopped the maneuver prior to completion and scan time of the image acquisition protocol.

Countries

Canada, Germany, South Africa, United Kingdom, United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026